Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Dr Atsuo Hata

Dr Atsuo Hata has over 50 years of experience working in the Japanese animal health industry. He is Animal Pharm’s freelance contributor for Japan. Dr Hata provides news, insight and analysis on a range of topics impacting the Japanese veterinary medicines sector.
Set Alert for Articles By Dr Atsuo Hata

Latest From Dr Atsuo Hata

Japan and China strengthen combined animal disease strategy

The governments of Japan and China have agreed to improve prevention efforts for the transboundary spread of epizootic diseases. 

Japan China

CSF outbreaks continue in Japan despite vaccination program

Three Japanese prefectural governments have recently confirmed classical swine fever (CSF) outbreaks on commercial farms.

Japan Classical swine fever

Japan monitoring survey details latest antimicrobial resistance figures

Japanese authorities have highlighted survey results of antimicrobial-resistant Salmonella subspecies and Staphylococus aureus isolated from cattle, pigs and chickens.

Japan Antimicrobial resistance

DS Pharma posts powerful first-half sales increase

Japan's DS Pharma Animal Health witnessed an 8.5% hike in revenues during the first half of fiscal 2019.

Financial Results Japan

Japan broadens CSF vaccination program

The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has started to vaccinate wild boar against classical swine fever (CSF).

Japan Classical swine fever

Zenoaq maintains healthy sales growth with strong start to fiscal 2019

Japan's Nippon Zenyaku Kogyou (Zenoaq) has replicated its recent powerful financial performance in the first half of the firm's fiscal 2019.

Nippon Zenyaku Kogyo Financial Results
See All